No abstract available
MeSH terms
-
Adult
-
Combined Modality Therapy
-
Humans
-
Immunocompromised Host
-
Immunoglobulins, Intravenous / therapeutic use
-
Immunosuppressive Agents / adverse effects*
-
Immunosuppressive Agents / therapeutic use
-
Male
-
Plasma Exchange
-
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / drug therapy*
-
Prednisone / therapeutic use
-
Psoriasis / chemically induced*
-
Psoriasis / immunology
-
Rituximab / adverse effects*
-
Rituximab / therapeutic use
Substances
-
Immunoglobulins, Intravenous
-
Immunosuppressive Agents
-
Rituximab
-
Prednisone